Elexacaftor (VX-445)

98%

  • Product Code: 65313
  CAS:    2216712-66-0
Molecular Weight: 597.65 g./mol Molecular Formula: C₂₆H₃₄F₃N₇O₄S
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: Elexacaftor (VX-445) is primarily used in the treatment of cystic fibrosis, a genetic disorder that affects the lungs and digestive system. It is often combined with other drugs like tezacaftor and ivacaftor to enhance its effectiveness. This combination works by improving the function of the defective CFTR protein, which is responsible for the movement of salt and water in and out of cells. By correcting this protein's function, the treatment helps to reduce the buildup of thick mucus in the lungs, thereby improving respiratory function and overall quality of life for patients. It is particularly beneficial for individuals with specific mutations in the CFTR gene, such as the F508del mutation. The use of elexacaftor has shown significant improvements in lung function, reduced frequency of pulmonary exacerbations, and better nutritional outcomes in clinical trials.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days ฿45,360.00
+
-
Elexacaftor (VX-445)
Elexacaftor (VX-445) is primarily used in the treatment of cystic fibrosis, a genetic disorder that affects the lungs and digestive system. It is often combined with other drugs like tezacaftor and ivacaftor to enhance its effectiveness. This combination works by improving the function of the defective CFTR protein, which is responsible for the movement of salt and water in and out of cells. By correcting this protein's function, the treatment helps to reduce the buildup of thick mucus in the lungs, thereby improving respiratory function and overall quality of life for patients. It is particularly beneficial for individuals with specific mutations in the CFTR gene, such as the F508del mutation. The use of elexacaftor has shown significant improvements in lung function, reduced frequency of pulmonary exacerbations, and better nutritional outcomes in clinical trials.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page